Responsibilities
Australian clinical trial sponsor responsibilities
The Australian sponsor role is a real accountability position, not a local address or administrative label.
For overseas companies, the important work is defining which sponsor responsibilities Clintrail holds locally and which operational inputs remain with the overseas team.
Short answer
The Australian sponsor is responsible for the initiation, management and financing, or arranging the financing, of the Australian clinical trial and carries sponsor responsibilities under Australian clinical trial requirements.
Core role
The sponsor role has legal, governance, and operational consequences.
Australian clinical trial sources describe the sponsor as responsible for starting, managing and financing, or arranging the financing of, the clinical trial. The sponsor is also responsible for appropriate approvals, compliance with approval conditions, ethics principles, and medico-legal risk.
That does not mean the Australian local sponsor performs every operational task itself. It means the responsibility split must be documented clearly and overseen properly.
Delegation
Tasks can be allocated, but responsibility needs to stay visible.
In practice, many trial activities are performed by the overseas company, sites, investigators, laboratories, vendors, consultants, or other providers.
The important sponsor-side question is whether each responsibility has a clear owner, whether the Australian sponsor has appropriate visibility, and whether the documentation supports the operating model.
Clintrail fit
Clintrail provides the Australian sponsor role.
Clintrail can hold the Australian sponsor role for the Australian clinical trial while the overseas company retains product ownership, protocol strategy, global development decisions, funding control, and broader program leadership.
- Clarify sponsor responsibility boundaries before startup.
- Align the sponsor role with CTN or CTA activity where relevant.
- Define sponsor oversight of delegated functions.
- Keep local sponsor responsibilities separate from global product and program ownership.
Practical matrix
Responsibility areas to define
A practical responsibility split helps overseas teams avoid assuming that the local sponsor role is only an administrative requirement.
| Area | Australian sponsor focus | Overseas sponsor input |
|---|---|---|
| Approvals | Confirm sponsor-side requirements for CTN or CTA activity, HREC and approving authority interfaces. | Provide protocol, product, safety, and site information. |
| Safety | Ensure safety responsibilities and reporting interfaces are allocated and monitored. | Provide global safety information and product risk context. |
| Records | Maintain sponsor-side visibility of required Australian records and notifications. | Provide study documents, amendments, reports, and operational updates as agreed. |
| Governance | Keep the Australian sponsor role and delegated functions clear during startup and conduct. | Continue to lead global program, funding, protocol, and product decisions. |
Common questions
Questions overseas teams usually ask
Does appointing Clintrail mean we transfer our whole global program?
No. Clintrail holds the Australian sponsor role for the Australian clinical trial. The overseas company keeps the global program, product ownership, funding, and broader development strategy.
Can sponsor duties be delegated?
Sponsor functions can be allocated to other parties, but the sponsor remains responsible for oversight of delegated functions. This is why a clear responsibility split matters.
What should be settled before startup?
Product type, pathway, sites, HREC and governance interfaces, safety reporting, insurance and indemnity, records, contracts, and the practical responsibility matrix should be settled early.
Source context
Grounded in Australian clinical trial requirements.
These pages are written for planning clarity. They do not replace legal, tax, regulatory, insurance, ethics, or clinical operations advice for a specific trial.
Related pages
Continue the sponsor-structure research
CTN vs CTA in Australia for overseas sponsors
A practical guide for overseas sponsors comparing Australia's CTN and CTA pathways and understanding where the Australian local sponsor fits.
Medical device trials in Australia with a local sponsor
How overseas medical device companies can use an Australian local sponsor for Australian clinical trials, including device-specific sponsor considerations.
IVD and diagnostics trials in Australia with a local sponsor
How overseas diagnostics and IVD companies can structure Australian clinical performance or diagnostics studies with an Australian local sponsor.
Run a clinical trial in Australia without setting up a local entity
How overseas companies can avoid forming an Australian subsidiary solely to hold the clinical trial sponsor role.
Next step
Need an Australian local sponsor?
Send through a short description of the clinical trial and your planned Australian activity. We will review it and get back to you soon.